COMMUNIQUÉS West-GlobeNewswire

EyePoint Pharmaceuticals Reports Fiscal Third Quarter 2018 Results

08/05/2018 - 22:10

Completed Substantive Strategic Initiatives to Accelerate Transformation to a Commercial Company Conference Call and Webcast Today, May 8th, at 4:30 p.m. ET WATERTOWN, Mass., May 08, 2018 (GLOBE NEWSWIRE) -- EyePoint [...]

Alder BioPharmaceuticals® Reports First Quarter 2018 Financial and Operating Results

08/05/2018 - 22:07

- 12-Month Data Presented at American Academy of Neurology (AAN) Annual Meeting Demonstrated Eptinezumab Further Reduced Migraine Risk Following Third and Fourth Quarterly Infusions - - Biologics License Application ( [...]

Ovid Therapeutics Reports First Quarter 2018 Financial Results and Corporate Progress

08/05/2018 - 22:06

Data readouts for Ovid’s two lead programs expected in 2018: OV101 STARS trial for adults and adolescents with Angelman syndrome (AS) in third quarter and TAK-935/OV935 Phase 1b/2a trial for adults with rare [...]

Prothena Reports First Quarter 2018 Financial Results and Provides R&D Update

08/05/2018 - 22:05

Net cash used in operating and investing activities was $31.8 million in the first quarter; quarter-end cash and restricted cash position of $433.1 million supports advancement through key milestones of R&D pipeline [...]

Corcept Therapeutics Announces First Quarter 2018 Financial results and Provides Corporate Update

08/05/2018 - 22:05

MENLO PARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT ), a company engaged in the discovery, development and commercialization of drugs to treat severe metabolic, oncologic [...]

Opiant Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results and Provides Corporate Update

08/05/2018 - 22:05

SANTA MONICA, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT ), a specialty pharmaceutical company developing pharmacological treatments for addictions, today reported [...]

miRagen Therapeutics Announces New Interim Data From Phase 1 Clinical Trial of Cobomarsen in Mycosis Fungoides

08/05/2018 - 22:05

Treatment resulted in durable improved quality of life Cobomarsen continued to be generally well tolerated at all dose levels evaluated Advancing into a Phase 2 clinical trial in second half of 2018 BOULDER, Colo., May [...]

Zafgen Reports First Quarter 2018 Operating and Financial Results

08/05/2018 - 22:05

Multiple ZGN-1061 abstracts accepted for presentation at upcoming American Diabetes Association (ADA) Scientific Sessions ZGN-1061 Phase 1 SAD / MAD data published in Diabetes, Obesity and Metabolism BOSTON, May 08, [...]

R1 Closes Acquisition of Intermedix Corporation

08/05/2018 - 22:05

Management team focused on customer care and a methodical integration CHICAGO, May 08, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc . (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management (RCM) [...]

OncoMed Announces First Quarter 2018 Financial Results and Operational Highlights

08/05/2018 - 22:05

Q1 Cash Balance of $88.4 Million—Cash through Q3 2019 First patient expected to be dosed in Phase 1b portion of anti-TIGIT trial in second quarter of 2018 Navicixizumab data expected in second half of 2018 REDWOOD CITY [...]

OPKO Health Reports First Quarter 2018 Financial Results

08/05/2018 - 22:05

Conference Call begins today at 4:30 p.m. Eastern Time MIAMI, May 08, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK ) reports financial results and business highlights for the three months ended March 31, 2018 [...]

Kura Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update

08/05/2018 - 22:05

– Registration-directed trial of tipifarnib in HRAS mutant head and neck squamous cell carcinomas (HNSCC) on track to initiate in second half of 2018 – – Data from multiple Phase 2 trials of tipifarnib in solid tumor [...]

AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2018

08/05/2018 - 22:05

GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 08, 2018 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC ), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]

Cutera Reports First Quarter 2018 Financial Results

08/05/2018 - 22:05

First Quarter Revenue of $34.1 Million; Increases 16% Year-over-Year North America System Revenue Grew 31% in the First Quarter BRISBANE, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Cutera, Inc. (NASDAQ: CUTR ) (“Cutera” [...]

VIVUS Reports First Quarter 2018 Financial Results

08/05/2018 - 22:05

Company provides business update on PANCREAZE ® acquisition, new Athyrium debt line and new management Company to host conference call today at 4:30pm ET CAMPBELL, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. ( [...]

Zosano Pharma to Host Conference Call on First Quarter 2018 Financial Results and Provide Operational Update

08/05/2018 - 22:05

FREMONT, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ: ZSAN ) (“Zosano” or the “Company”) a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of [...]

Tabula Rasa HealthCare Announces First Quarter 2018 Operating Results

08/05/2018 - 22:05

First Quarter 2018 Revenue of $43.9 million, growth of 57%; 2018 Revenue Guidance Increased MOORESTOWN, N.J., May 08, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC ), a healthcare [...]

OpGen Reports First Quarter 2018 Financial Results and Provides a Business Update

08/05/2018 - 22:05

Revenue increases 10% to $0.8 million, net loss decreases 39% to $3.0 million Conference call begins at 4:30 p.m. Eastern time today GAITHERSBURG, Md., May 08, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) today [...]

Dynavax Reports First Quarter 2018 Financial Results

08/05/2018 - 22:05

Update on Initial Progress of HEPLISAV-B ® Commercial Launch Conference Call to be Held at 4:30pm ET/1:30pm PT BERKELEY, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) today [...]